Participation to TERMIS EU 2025
TERMIS EU 2025 May 15th, 2025, Vienna, Austria Our co-founder, COO/CSO Regina Grillari is a selected speaker at Termis EU Congress
15
05, 2025
8
05, 2025
Participation to Cell Culture Days 2025
Cell Culture Days 2025 May 8th, 2025, Vienna, AustriaOur co-founder, COO/CSO Regina Grillari is an invited speaker at the Cell Culture Days
16
04, 2025
Newly released telomerized trophoblasts
Newly released telomerized trophoblasts April 16th, 2025, Vienna, Austria We are thrilled to announce a newest addition to our cell portfolio:
8
04, 2025
Participation to ISEV 2025
Meet us at ISEV2025 April 8th, 2025, Vienna, Austria Visit us at booth B13 at the ISEV 2025 meeting in Vienna,
1
04, 2025
Newly released telomerized endometrium-derived MSC
Newly released telomerized endometrium-derived MSC April 1st, 2025, Vienna, AustriaWe are thrilled to announce the newest addition to our cell portfolio: Telomerized Endometrium-derived MSC!A
14
03, 2025
3D imaging of RPTEC/TERT1 in microphysiological systems
3D imaging of RPTEC/TERT1 in microphysiological systems March 14th, 2025, Vienna, Austria We are pleased to share a new application note
10
03, 2025
New Cell Systems developed in collaboration with AIM Biotech
New Cell Systems developed in collaboration with AIM Biotech March 10th, 2025, Vienna, Austria Two innovative 3D assay kits for advanced angiogenesis
26
11, 2024
Recently published article on Cyclosporin A toxicity on endothelial cell
Recently published article on the mechanistic toxicology of Cyclosporin A and its effects on angiogenesis November 26th, 2024, Vienna, Austria A recent
4
11, 2024
Recently published article on generating endothelial and vascular smooth muscle cells from PBMC and urine-derived iPSCs
Recently published article on generating endothelial and vascular smooth muscle cells from PBMC and urine-derived iPSCs November 4th, 2024, Vienna, AustriaA recent
4
11, 2024
Partnering with AIM Biotech
Partnering with AIM Biotech November 4th, 2024, Vienna, Austria We are thrilled to announce that we have partnered with Singapore-based AIM